320. Inherited glycosylphosphatidylinositol deficiency Clinical trials / Disease details


Clinical trials : 3 Drugs : 2 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs051180113
01/04/201911/03/2019Novel replacement therapy for inherited GPI deficiencyNovel replacement therapy for inherited GPI deficiency - Novel replacement therapy for inherited GPI deficiency Inherited GPI deficiency
Inherited GPI deficiency
Folinic acid 1mg/kg/day in three divided dose to start. If the 5-MTHF concentration in cerebrospinal fluid will be low after one month, folinic acid will be uo to 2-5mg/kg/day.The period of administration is six months in principle.Nabatame ShinNULLRecruitingNot applicableNot applicableBoth5N/AJapan
2JPRN-UMIN000030314
2019/04/0115/01/2018Novel replacement therapy for inherited GPI deficiency (IGD)Novel replacement therapy for inherited GPI deficiency (IGD) - Novel replacement therapy for inherited GPI deficiency (IGD) Inherited GPI deficiencyFolinic acid 1mg/kg/day in three divided dose to start. If the 5-MTHF concentration in cerebrospinal fluid will be low after one month, folinic acid will be uo to 2-5mg/kg/day.The period of administration is six months in principle.Osaka UniversityNULLRecruitingNot applicableNot applicableMale and Female5Not selectedJapan